Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124784632 | 12478463 | 2 | F | 2016 | 20160718 | 20160618 | 20160723 | EXP | CA-009507513-1603CAN005234 | MERCK | 0.00 | F | Y | 0.00000 | 20160723 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124784632 | 12478463 | 1 | PS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | 140 MG DAILY FOR 5 DAYS CYCLE | 21029 | 140 | MG | CAPSULE | |||||||
| 124784632 | 12478463 | 2 | SS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | 140 MG DAILY FOR 21 DAYS CYCLE | 21029 | 140 | MG | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124784632 | 12478463 | 1 | Glioblastoma multiforme |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124784632 | 12478463 | DE |
| 124784632 | 12478463 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124784632 | 12478463 | Brain neoplasm | |
| 124784632 | 12478463 | Cerebral haemorrhage | |
| 124784632 | 12478463 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124784632 | 12478463 | 2 | 20151203 | 0 |